Serena Macrini

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Alessio Cortellini, Marco Tucci, Vincenzo Adamo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 264 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone et al. · European Journal of Cancer · 2020 · 117 citations

Life Sciences, Immunology, Oncology +17

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Alessio Cortellini, Antonio D’Alessio, Siobhan Cleary et al. · Clinical Cancer Research · 2023 · 74 citations · Full text

Medicine, Immunology, Oncology +16

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

Olga Nigro, Graziella Pinotti, Federica De Galitiis et al. · European Journal of Cancer · 2020 · 69 citations

Life Sciences, Immunology, Oncology +17

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience

Maurizio Valeriani, Luca Marinelli, Serena Macrini et al. · Radiation Oncology · 2019 · 24 citations · Full text

Medicine, Oncology, Pharmacology +16